BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs ...

Cambridge is seizing a unique moment to amplify the global impact of its world-leading research by opening a new office in ...

The Cambridge Independent Business Awards 2025 are now open for entry. ... technology, marketing, professional office and supply chain and engineering roles. David Culley, executive director of Pure, ...

AstraZeneca previously announced on Feb. 7 that it had received a Notice of Transfer to the Prosecutor and an Appraisal Opinion from the Shenzhen City Customs Office regarding suspected unpaid import ...

AstraZeneca Q1 sales rose 7% YoY to $13.59 billion, missing estimates; Earnings per ADS beat at $1.25 vs. $1.11 consensus. Oncology revenue jumped 10% to $5.64 billion; Tagrisso, Imfinzi, and ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre together with major research and manufacturing agreements that will ...

The average house price in Cambridge was £515,000, external in December, according to the Office for National Statistics, significantly higher than the average for Great Britain of £271,000.

Cambridge may be known for its chapels, colleges and winding lanes. But something else sets the city apart: 28% of residents hold a non-UK passport, compared with an England and Wales average of 10%.

Other biopharma companies have also been expanding their footprint in Cambridge, with heavyweights like Takeda and AstraZeneca set to occupy 600,000 square feet and 570,000 sq ft in properties ...

A few weeks later, Donelan was invited to visit AstraZeneca’s research and development site in Cambridge, the heartland of Britain’s life sciences sector, where she was treated to a glitzy ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca: Revenue and EPS summary Financial performance for FY 2024 (Growth numbers at constant exchange rates) Total Revenue up 21% to $54,073m, driven by ...

Cambridge headquartered global pharma company AstraZeneca is investing C$820 million (US$570m) in Canada, creating more than 700 high-skilled jobs across all areas of the business. The investment will ...